Dozens of staff at the NIH walked out of a recent town hall meeting after Director Dr Jay Bhattacharya suggested the agency may have helped fund research that caused the COVID-19 pandemic.

Apotex has launched the first generic version of Tasigna (nilotinib), a TKI used to treat adult and pediatric patients with Ph+ CML.

The FDA expects that randomized, controlled trial data on clinical outcomes will be needed before COVID-19 vaccines can be approved for patients who are 6 months to 64 years of age and do not have ...

Cancer organizations are urging researchers, oncologists, and other stakeholders to advocate for cancer research.

We need to rethink our approach in responding to cancers in our younger women patients,” said Hope S. Rugo, MD.

The median time to treatment initiation across all cancer types increased from 21 days in 2004 to 28 days in 2015. The median time to treatment initiation is increasing across cancer types, and this ...

These findings support the need for a phase III randomized controlled trial to definitively determine whether the addition of an antiangiogenic to a second or even a third-generation TKI provides ...

Health care data breaches that compromised protected health information more than doubled from 2010 to 2024 in the US, data suggest.

We want you to take advantage of everything Cancer Therapy Advisor has to offer. To view unlimited content, log in or register for free.

Launch prices for self-administered targeted anticancer therapies have grown precipitously,” researchers wrote.

The results of our study suggest a concerning pattern in cancer center advertising, particularly among top-ranked institutions,” researchers wrote.

(HealthDay News) — China has promised to give $500 million to the World Health Organization (WHO) over the next 5 years, positioning itself to become the group’s top donor, The Washington Post ...